Charles Schwab’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $937M | Buy |
|
|||||
2025
Q1 | $865M | Buy |
|
|||||
2024
Q4 | $757M | Buy |
|
|||||
2024
Q3 | $672M | Buy |
|
|||||
2024
Q2 | $613M | Buy |
|
|||||
2024
Q1 | $541M | Buy |
|
|||||
2023
Q4 | $445M | Buy |
|
|||||
2023
Q3 | $404M | Buy |
|
|||||
2023
Q2 | $403M | Sell |
|
|||||
2023
Q1 | $372M | Sell |
|
|||||
2022
Q4 | $348M | Buy |
|
|||||
2022
Q3 | $285M | Sell |
|
|||||
2022
Q2 | $289M | Sell |
|
|||||
2022
Q1 | $345M | Buy |
|
|||||
2021
Q4 | $321M | Buy |
|
|||||
2021
Q3 | $319M | Buy |
|
|||||
2021
Q2 | $284M | Buy |
|
|||||
2021
Q1 | $251M | Sell |
|
|||||
2020
Q4 | $250M | Buy |
|
|||||
2020
Q3 | $245M | Buy |
|
|||||
2020
Q2 | $220M | Buy |
|
|||||
2020
Q1 | $197M | Buy |
|
|||||
2019
Q4 | $269M | Buy |
|
|||||
2019
Q3 | $237M | Buy |
|
|||||
2019
Q2 | $243M | Buy |
|
|||||
2019
Q1 | $212M | Buy |
|
|||||
2018
Q4 | $193M | Buy |
|
|||||
2018
Q3 | $205M | Buy |
|
|||||
2018
Q2 | $173M | Buy |
|
|||||
2018
Q1 | $141M | Buy |
|
|||||
2017
Q4 | $122M | Buy |
|
|||||
2017
Q3 | $138M | Buy |
|
|||||
2017
Q2 | $129M | Sell |
|
|||||
2017
Q1 | $132M | Sell |
|
|||||
2016
Q4 | $117M | Buy |
|
|||||
2016
Q3 | $128M | Buy |
|
|||||
2016
Q2 | $88.8M | Buy |
|
|||||
2016
Q1 | $65.6M | Buy |
|
|||||
2015
Q4 | $63.2M | Sell |
|
|||||
2015
Q3 | $57.3M | Sell |
|
|||||
2015
Q2 | $61.8M | Sell |
|
|||||
2015
Q1 | $73.2M | Buy |
|
|||||
2014
Q4 | $53.6M | Buy |
|
|||||
2014
Q3 | $45.6M | Sell |
|
|||||
2014
Q2 | $53.6M | Sell |
|
|||||
2014
Q1 | $62.5M | Buy |
|
|||||
2013
Q4 | $54.8M | Sell |
|
|||||
2013
Q3 | $59M | Sell |
|
|||||
2013
Q2 | $47.5M | Buy |
|